---
document_datetime: 2025-01-14 13:54:32
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ketoconazole-esteve-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: ketoconazole-esteve-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.8588827
conversion_datetime: 2025-12-25 03:48:07.455119
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Ketoconazole Esteve

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                         | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IAIN/0025/G          | This was an application for a group of variations. A.2.a - Administrative change - Change in the (invented) name of the medicinal product for CAPs A.1 - Administrative change - Change in the name and/or address of the MAH | 13/01/2025                          |                                             | SmPC, Labelling and PL           |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0024             | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                           | 13/06/2024   | n/a   |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| IA/0023             | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State                                                                                                                                                                                                                                                                                                                          | 02/04/2024   | n/a   |                                   |
| IA/0022             | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                    | 16/01/2023   | n/a   |                                   |
| PSUSA/10316 /202111 | Periodic Safety Update EU Single assessment - ketoconazole (centrally authorised product only)                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 10/06/2022   | n/a   | PRAC Recommendation - maintenance |
| IA/0019/G           | This was an application for a group of variations. B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the | 30/09/2021   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

|                     | from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer   |            |            |                                  |                                                                                                                                                                                                                                                                                |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10316 /202011 | Periodic Safety Update EU Single assessment - ketoconazole (centrally authorised product only)                                                                                                                                                                                                                                                                                                                                  | 10/06/2021 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                              |
| IA/0018             | A.6 - Administrative change - Change in ATC Code/ATC Vet Code                                                                                                                                                                                                                                                                                                                                                                   | 20/04/2021 | 02/06/2022 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                |
| PSUSA/10316 /201911 | Periodic Safety Update EU Single assessment - ketoconazole (centrally authorised product only)                                                                                                                                                                                                                                                                                                                                  | 11/06/2020 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                              |
| T/0015              | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                             | 11/09/2019 | 07/11/2019 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                |
| R/0014              | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                         | 29/05/2019 | 31/07/2019 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Ketoconazole HRA in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| PSUSA/10316 /201811 | Periodic Safety Update EU Single assessment - ketoconazole (centrally authorised product only)                                                                                                                                                                                                                                                                                                                                  | 14/06/2019 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                              |

<div style=\"page-break-after: always\"></div>

| IAIN/0012           | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                               | 16/01/2019   | 31/07/2019   | SmPC, Labelling and PL   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10316 /201805 | Periodic Safety Update EU Single assessment - ketoconazole (centrally authorised product only)                                                                                                                                                                                                                           | 29/11/2018   | n/a          |                          | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| N/0011              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                         | 24/08/2018   | 31/07/2019   | Labelling                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| PSUSA/10316 /201711 | Periodic Safety Update EU Single assessment - ketoconazole (centrally authorised product only)                                                                                                                                                                                                                           | 14/06/2018   | n/a          |                          | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| PSUSA/10316 /201705 | Periodic Safety Update EU Single assessment - ketoconazole (centrally authorised product only)                                                                                                                                                                                                                           | 30/11/2017   | n/a          |                          | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| PSUSA/10316 /201611 | Periodic Safety Update EU Single assessment - ketoconazole (centrally authorised product only)                                                                                                                                                                                                                           | 22/06/2017   | 22/08/2017   | SmPC and PL              | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10316/201611.                                                                                                                                                                                                                                                                                                                                                            |
| PSUSA/10316 /201605 | Periodic Safety Update EU Single assessment - ketoconazole (centrally authorised product only)                                                                                                                                                                                                                           | 15/12/2016   | 23/02/2017   | SmPC and PL              | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10316/201605.                                                                                                                                                                                                                                                                                                                                                            |
| II/0005             | Update of section 4.5 to include information related to interactions with CYP 2A6, 2C19, and 2E1, CYP2B6, 2C9/C8 and 2D6 and antidiabetics (tolbutamide).The Package Leaflet is updated in accordance. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 15/09/2016   | 23/02/2017   | SmPC and PL              | Update of the section 4.5 of the SmPC to reflect that in vitro data indicate that ketoconazole is an inhibitor of CYP1A2 and does not significantly inhibit CYP 2A6, 2C19, and 2E1. At clinically relevant concentrations inhibition of CYP2B6, 2C9/C8, and 2D6 by ketoconazole cannot be excluded. In addition, table 1 (interactions and recommendations for co-administration) is updated regarding co-administration with tolbutamide, to recommend careful monitoring and possible need for dose |

<div style=\"page-break-after: always\"></div>

|                     |                                                                                                                                                                                                                                                                                                                                                                                              |            |            |                 | adjustment, due to an expected increase in tolbutamide exposure (1.7 fold).                                                                                           |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10316 /201511 | Periodic Safety Update EU Single assessment - ketoconazole (centrally authorised product only)                                                                                                                                                                                                                                                                                               | 23/06/2016 | 31/08/2016 | SmPC and PL     | Please refer to ketoconazole HRA-PSUSA 010316-201511 EPAR: Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation. |
| PSUSA/10316 /201505 | Periodic Safety Update EU Single assessment - ketoconazole (centrally authorised product only)                                                                                                                                                                                                                                                                                               | 17/12/2015 | 22/02/2016 | SmPC and PL     | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10316/201505.                            |
| IAIN/0002/G         | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 13/03/2015 | 22/02/2016 | Annex II and PL |                                                                                                                                                                       |
| IAIN/0001           | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                              | 08/01/2015 | n/a        |                 |                                                                                                                                                                       |